Telapristone acetate (Proellex)

telapristone acetate · Repros Therapeutics Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Telapristone acetate (Proellex), covering 2019-06-14 to 2019-06-14. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of Telapristone Acetate (Proellex®) Administered Vaginally for the Treatment of Uterine Fibroids [Phase 2]

See pricing